By Lauran Neergaard
The Associated Press
WASHINGTON - Allergy sufferers who rejoiced when Claritin went over the counter are now dealing with an additional headache: At nearly $1 a pill, nonprescription Claritin is more expensive for insured patients who were used to a $10 co-pay for a whole bottle.
Many insurance companies are also making it harder to get prescriptions for other drugs, charging $35 to $50 for competitors Allegra or Zyrtec. Some demand proof that patients tried, and failed, Claritin for a few weeks before even allowing their doctors to write a prescription for an alternative.
"It's a real hassle," says Dr. Gordon Raphael, a Bethesda, Md., allergist who reports being inundated with calls from patients desperate for him to certify they need a new medication.
Patients rethinking their allergy choices because of cost could find that other medicines actually control their symptoms better.
Although Claritin once was the best-selling prescription allergy medicine, specialists like Raphael cite research showing there are more-effective choices for the severely afflicted.
In fact, study after study finds prescription steroid nasal sprays - sold under such names as Flonase, Nasacort and Nasonex - the most-effective hay fever treatment.
Yet by far, most allergy sufferers pop pills.
If Claritin worked well for you, stick with it, allergists say.
The only nonsedating option available without a prescription, it is most helpful for mild to moderate allergies.
While the well-insured may fuss at the new OTC price, they won't have the time and expense of a doctor's visit.
And the uninsured will pay far less for Claritin than they had been.
Also, generic versions have just begun selling at 65 to 80 cents a pill; look for Claritin's chemical name, loratadine.
LOCAL BUSINESS NEWS
Iraqi cards now from Norwood
Gambling boats win 1st quarter
Judge OKs National Steel sale
CFC rejects shareholder proposal
Morning Memo: Hot tips & news to start your business day
NATIONAL BUSINESS NEWS
War weighs on economic index
Cost of Claritin nothing to sneeze at
United tests $7 breakfast, $10 lunch
American Airlines' stock nosedives
Trade deficit leaves container surplus
Music heard again at Stax studio site